BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17325701)

  • 1. TUNEL - an efficient prognosis predictor of salivary malignancies.
    Ben-Izhak O; Laster Z; Araidy S; Nagler RM
    Br J Cancer; 2007 Apr; 96(7):1101-6. PubMed ID: 17325701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognostic significance of Cks1 in salivary cancer.
    Nagler RM; Ben-Izhak O; Ostrovsky D; Golz A; Hershko DD
    Cancer Invest; 2009 Jun; 27(5):512-20. PubMed ID: 19296297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The salivary tip of the p53 mutagenesis iceberg: novel insights.
    Ben-Izhak O; Laster Z; Akrish S; Muska E; Gan S; Nagler RM
    Cancer Biomark; 2009; 5(1):23-31. PubMed ID: 19242059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TUNEL as a tumor marker of tongue cancer.
    Ben-Izhak O; Laster Z; Akrish S; Cohen G; Nagler RM
    Anticancer Res; 2008; 28(5B):2981-6. PubMed ID: 19031943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands.
    Yin HF; Okada N; Takagi M
    Pathol Int; 2000 Aug; 50(8):603-9. PubMed ID: 10972857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki67 and salivary cancer.
    Ben-Izhak O; Akrish S; Nagler RM
    Cancer Invest; 2008 Dec; 26(10):1015-23. PubMed ID: 19093259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL).
    Hellquist HB; Sundelin K; Di Bacco A; Tytor M; Manzotti M; Viale G
    J Pathol; 1997 Mar; 181(3):323-9. PubMed ID: 9155720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands.
    Shieh YS; Hung YJ; Hsieh CB; Chen JS; Chou KC; Liu SY
    Ann Surg Oncol; 2009 Mar; 16(3):751-60. PubMed ID: 19116756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
    Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
    Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of Ki-67 in salivary gland carcinomas.
    Larsen SR; Bjørndal K; Godballe C; Krogdahl A
    J Oral Pathol Med; 2012 Sep; 41(8):598-602. PubMed ID: 22530699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
    Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
    Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of adenoid cystic carcinoma of minor salivary glands.
    Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
    Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
    Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.
    Tang QL; Fan S; Li HG; Chen WL; Shen XM; Yuan XP; Chang SH; Song Y
    Oral Oncol; 2011 May; 47(5):365-70. PubMed ID: 21439895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.